علاج الخط الأول للليمفوما الكبيرة المنتشرة من الخلايا البائية

For decades, chemoimmunotherapy with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) has been the standard initial DLBCL treatment.

For patients with advanced-stage disease, those with low-risk DLBCL (IPI 0-1) and those with the GCB subtype have very good outcomes when treated with 6 cycles of standard R-CHOP treatment.